Why Novartis’ Drug Trial Results Are Blowing Up Amgen Stock
Barrons.com · 2026-09-09
STOCKS · PHARMA
AMGN · Amgen
Latest news, signals, and AI analysis for Amgen (AMGN) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent AMGN News
Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO Downgrade
InvestorsHub · 2026-09-09
Amgen and AstraZeneca report positive lung cancer trial results
Investing.com · 2026-09-09
Stocks making the biggest moves midday: Amgen, Qualcomm, Expedia, CoreWeave & more
CNBC Top · 2026-09-08
Amgen: Why Rivals' Cholesterol Drug Fail Is Bad News For The Pharma (Rating Downgrade)
Seeking Alpha · 2026-09-08
Related Tickers
$JNJ · Johnson & Johnson$LLY · Eli Lilly$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$NVO · Novo NordiskFrequently Asked Questions
What sector does AMGN belong to?
AMGN (Amgen) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time AMGN news?
Catalayer aggregates AMGN coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/AMGN.
How fast are AMGN news alerts on Catalayer?
News is polled every 30–60 seconds. AMGN-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for AMGN?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every AMGN story.
Is AMGN covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support AMGN. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.
Track AMGN in real time
Set up a monitor to get alerted when new news hits.